Plunkett Research Online: Sangamo Therapeutics Inc

SANGAMO THERAPEUTICS INC (SGMO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemoph.....



Sangamo Therapeutics Inc
Ticker: SGMO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510 970-6000
Fax: 510 236-8951
Address: 7000 Marina Boulevard
Brisbane, CA 94005 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Research & Development
Gene Expression Regulation Therapies
Transcription Factor Technology
Biotechnology
Clinical Testing
Cell Therapy
Genome Editing
Technologies
Contacts Description
Alexander MacraeCEO/President/Director
Prathyusha DuraibabuCFO/Chief Accounting Officer/Senior VP
See More
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemoph.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: